A Study of LY2484595 on the Electrical Activity of the Heart

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY2484595

Administered orally once daily for 10 days.

DRUG

Placebo

Administered orally once daily for 10 days.

DRUG

Moxifloxacin

Single dose administered orally.

Trial Locations (2)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

47710

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01537887 - A Study of LY2484595 on the Electrical Activity of the Heart | Biotech Hunter | Biotech Hunter